Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$40,040
+$1,887 QoQ
Shares Held
143
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#873
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Park Place Capital Corp holds $1,838,593 across 12 Diagnostics & Research names. LH ranks #6 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,689 | $1,348,155 | |
| 2 | DHR |
Danaher Corp /De/
|
725 | $138,098 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
208 | $110,154 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
88 | $46,326 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
185 | $41,956 | |
| 6 | LH |
Labcorp Holdings Inc.
This page
|
143 | $40,040 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
207 | $39,996 | |
| 8 | A |
Agilent Technologies, Inc.
|
233 | $30,949 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,040 | 143 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $38,153 | 143 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $35,875 | 143 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $33,298 | 116 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $30,451 | 116 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $26,997 | 116 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $26,601 | 116 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $25,923 | 116 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $22,996 | 113 | Shares | Sole | 2024-07-02 | |
| No filing history on record for this holder in this stock. | ||||||